IKZF1 and acute lymphoblastic leukemia: COG AALL1521 (NCT02723994) is testing the role of JAK inhibition in Ph-like ALL with EPOR and JAK2 rearrangements, or CRLF2 rearrangements, which also co-occur with IKZF1 deletion [90].